Granisetron Completed Phase 2 Trials for Vomiting / cancer treatment / Nausea Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care2
clinicaltrials.gov IdentifierTitleDrugs
NCT00503386Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and Vomiting
NCT00450853Randomized Crossover Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Granisetron in Cancer Patients